Table 2.
Demographic and baseline clinical data
| Prazosin (n=35) | Prazosin plus antivenom (n=35) | |
|---|---|---|
| Mean (SD) age in years | 32.4 (15.7) | 31.1 (21.1) |
| Sex | ||
| Male | 24 (68.6%) | 27 (77.1%) |
| Female | 11 (31.4%) | 8 (22.9%) |
| Children <18 years | ||
| Boys | 5(26.3%) | 9(47.3%) |
| Girls | 2 (10.5%) | 3(15.7%) |
| Mean (SD) time between sting and admission | 94.7 (43.9) | 115.3 (66) |
| Vomiting | 29 (82.9%) | 29 (82.9%) |
| Paraesthesia | 22 (62.9%) | 23 (65.7%) |
| Sweating | 34 (97.1%) | 35 (100 %) |
| Salivation | 25 (71.4%) | 30 (85.7%) |
| Cold extremities | 34 (97.1%) | 35 (100%) |
| Priapism | 14 /24 (58.3%) | 17/ 27 (62.9%) |
| Bradycardia | 10 (28.6%) | 10 (28.6%) |
| Transient systolic murmur | 17 (48.6%) | 19 (54.3%) |